| Pharmacokinetics and Safety/Tolerability Profile of CKD-379 (NCT05452525) | Chong Kun Dang Pharmaceutical | 2022-07-26 |
| Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 (NCT05274880) | Chong Kun Dang Pharmaceutical | 2022-06-21 |
| Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) (NCT06030544) | Spanish National Research Council | 2022-02-25 |
| Dose Response of Eccentric Exercise on Glycemic Control in Type II Diabetes Mellitus (NCT04790526) | Riphah International University | 2021-07-12 |
| Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids (NCT03912363) | Geisinger Clinic | 2019-11-01 |
| Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus (NCT04665284) | Getz Pharma | 2019-06-01 |
| Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg (NCT03601910) | Chong Kun Dang Pharmaceutical | 2018-07-16 |
| A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated (NCT03550378) | MedImmune LLC | 2018-06-29 |
| A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM (NCT03907202) | KeyBioscience AG | 2018-04-17 |
| Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes (NCT02761018) | Mike O'Callaghan Military Hospital | 2017-08-08 |
| Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan (NCT03084965) | AstraZeneca | 2017-05-12 |
| Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I) (NCT03025919) | Zhongda Hospital | 2017-01-01 |
| Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine (NCT03615755) | Hendry Irawan | 2016-12-27 |
| Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus (NCT02805361) | AstraZeneca | 2016-08-21 |
| A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus (NCT02749435) | AstraZeneca | 2016-05-03 |
| SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2 (NCT02592421) | The University of Texas Health Science Center at San Antonio | 2015-10-23 |
| Whey Protein Effect on Glycaemic and Appetite Responses in T2D (NCT02903199) | Northumbria University | 2015-07-01 |
| Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus (NCT03059719) | PegBio Co., Ltd. | 2015-04-08 |
| Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients (NCT02274740) | Sanofi | 2015-04-01 |
| A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients. (NCT02156349) | Hoffmann-La Roche | 2014-05-14 |
| Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM (NCT02065674) | Fr Muller Homoeopathic Medical College | 2014-02-01 |
| A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease (NCT02446054) | Celio Technology Inc. | 2014-02-01 |
| Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patients. (NCT02012478) | University of Pennsylvania | 2014-02-01 |
| The Effect of Linagliptin on Mitochondrial and Endothelial Function (NCT01969084) | Beth Israel Deaconess Medical Center | 2013-10-01 |
| A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers (NCT01952535) | Hua Medicine Limited | 2013-09-01 |
| Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus (NCT01868646) | Materia Medica Holding | 2013-05-07 |
| Lipid Biomarkers for Diabetic Heart Disease (NCT01752842) | Washington University School of Medicine | 2013-03-01 |
| Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD (NCT01785524) | Duke University | 2013-02-01 |
| A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics (NCT01644201) | InovoBiologic Inc. | 2012-10-01 |
| A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus (NCT01514838) | Astellas Pharma Inc | 2012-04-23 |
| Mobile Health Technology as an Intervention for Diabetes Self-Management (NCT01546844) | HealthInsight | 2012-03-01 |
| Effects of Krill Oil on Endothelial Function in Patients With Type 2 Diabetes Mellitus (NCT02091193) | Danbury Hospital | 2012-03-01 |
| The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes (NCT01648244) | Walter Reed National Military Medical Center | 2012-03-01 |
| A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM (NCT01523405) | AstraZeneca | 2012-03-01 |
| A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients (NCT01505426) | Astellas Pharma Inc | 2011-11-28 |
| Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus (NCT00737152) | American Scitech International | 2011-07-01 |
| Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus (NCT01261494) | Genfit | 2010-12-01 |
| Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device. (NCT01262586) | Novartis Pharmaceuticals | 2010-11-01 |
| Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes (NCT01196728) | CellMed AG, a subsidiary of BTG plc. | 2010-09-01 |
| Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients (NCT01020123) | AstraZeneca | 2009-10-01 |
| Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea (NCT00995787) | AstraZeneca | 2009-10-01 |
| Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients (NCT00997152) | Akros Pharma Inc. | 2009-09-01 |
| Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM) (NCT00960791) | AstraZeneca | 2009-07-01 |
| Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes (NCT01076829) | University of California, Los Angeles | 2009-07-01 |
| Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients (NCT00929539) | Akros Pharma Inc. | 2009-06-01 |
| Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure (NCT00894868) | Novartis Pharmaceuticals | 2009-05-01 |
| Metabolomics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy (NCT00887302) | East Carolina University | 2009-03-25 |
| Yellow Pea Fractions and Short-term Food Intake, Subjective Appetite and Glycemic Response (NCT01242059) | University of Toronto | 2009-01-01 |
| Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes (NCT00863954) | pico-tesla Magnetic Therapies, LLC | 2009-01-01 |
| Yellow Pea Protein and Fibre and Short Term Food Intake (NCT01255085) | University of Toronto | 2008-05-01 |
| Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans (NCT01165190) | Arizona State University | 2008-05-01 |
| Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria (NCT00561171) | Speedel Pharma Ltd. | 2007-11-01 |
| Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus (NCT00540462) | Min-Sheng General Hospital | 2007-08-01 |
| Innovative Strategies For Risk Reduction Following CABG (NCT00462436) | Unity Health Toronto | 2007-02-01 |
| Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia (NCT00344370) | Kowa Research Europe | 2006-08-01 |
| Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia (NCT00309751) | Kowa Research Europe | 2005-12-01 |
| Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus (NCT00306176) | Aristotle University Of Thessaloniki | 2005-01-01 |
| A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014) (NCT00481663) | Merck Sharp & Dohme LLC | 2003-08-19 |
| Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study (NCT00309712) | Intermountain Health Care, Inc. | 2002-08-01 |
| Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease (NCT00282360) | IRCCS San Raffaele | 1999-02-01 |